Mr. Mark Upsdell reports

RAPID DOSE ANNOUNCES CHANGE OF AUDITOR

Rapid Dose Therapeutics Corp. has changed its auditor from MNP LLP to SRCO Professional Corp., chartered professional accountants. At the request of the company, the former auditor resigned as the auditor of the company, effective May 16, 2023, and the board of directors of the company appointed the successor auditor as the company's auditor, effective May 16, 2023, to hold office until the next annual meeting of the company.

There were no modified opinions in the former auditor's audit reports for the company's two most recent financial years and ending at the date of the resignation of the former auditor. There are no reportable events (as the term is defined in National Instrument 51-102, Continuous Disclosure Obligations) between the company and the former auditor.

In accordance with NI 51-102, the company's notice of change of auditor, together with the required letters from the former auditor and the successor auditor, have been filed on SEDAR.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.

We seek Safe Harbor.